Amy Emerson is the Chief Executive Officer (CEO) at MAPS PBC. As the CEO, Amy has led the growth and development of this new subsidiary and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC.